Aurobindo Pharma informs about disclosure

01 Jul 2023 Evaluate

Further to its letter dated May 27, 2023 regarding sale and transfer of all equity shares held by the Company in Auro Vaccines, a wholly owned subsidiary of the Company, to Curateq Biologics, another wholly owned subsidiary of the Company, as part of verticalization of business operations, Aurobindo Pharma has informed that the said transaction of sale and transfer of shares has been completed and Auro Vaccines has become a step-down subsidiary of the Company with effect from July 1, 2023.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1129.20 -11.10 (-0.97%)
21-Jan-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.10
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 875.10
Lupin 2140.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×